Protein synthesis and its control in neuronal cells with a focus on vanishing white matter disease
Protein synthesis and its control in neuronal cells with a focus on vanishing white matter disease
Protein synthesis (also termed mRNA translation) is a key step in the expression of a cell's genetic information, in which the information contained within the coding region of the mRNA is used to direct the synthesis of the new protein, a process that is catalysed by the ribosome. Protein synthesis must be tightly controlled, to ensure the right proteins are made in the right amounts at the right time, and must be accurate, to avoid errors that could lead to the production of defective and potentially damaging proteins. In addition to the ribosome, protein synthesis also requires proteins termed translation factors, which mediate specific steps of the process. The first major stage of mRNA translation is termed 'initiation' and involves the recruitment of the ribosome to the mRNA and the identification of the correct start codon to commence translation. In eukaryotic cells, this process requires a set of eIFs (eukaryotic initiation factors). During the second main stage of translation, 'elongation', the ribosome traverses the coding region of the mRNA, assembling the new polypeptide: this process requires eEFs (eukaryotic elongation factors). Control of eEF2 is important in certain neurological processes. It is now clear that defects in eIFs or in their control can give rise to a number of diseases. This paper provides an overview of translation initiation and its control mechanisms, particularly those examined in neuronal cells. A major focus concerns an inherited neurological condition termed VHM (vanishing white matter) or CACH (childhood ataxia with central nervous system hypomyelination). VWM/CACH is caused by mutations in the translation initiation factor, eIF2B, a component of the basal translational machinery in all cells.
autism spectrum disorder (asd), childhood ataxia with central nervous system hypomyelination (cach), disease, eukaryotic initiation factor 2B (eIF2B), protein synthesis, vanishing white matter (vwm)
1298-1310
Pavitt, Graham D.
cef4d91d-f07d-44ad-8aaa-74670d2b1ec0
Proud, Christopher G.
59dabfc8-4b44-4be8-a17f-578a58550cb3
2009
Pavitt, Graham D.
cef4d91d-f07d-44ad-8aaa-74670d2b1ec0
Proud, Christopher G.
59dabfc8-4b44-4be8-a17f-578a58550cb3
Pavitt, Graham D. and Proud, Christopher G.
(2009)
Protein synthesis and its control in neuronal cells with a focus on vanishing white matter disease.
Biochemical Society Transactions, 37 (6), .
(doi:10.1042/BST0371298).
(PMID:19909266)
Abstract
Protein synthesis (also termed mRNA translation) is a key step in the expression of a cell's genetic information, in which the information contained within the coding region of the mRNA is used to direct the synthesis of the new protein, a process that is catalysed by the ribosome. Protein synthesis must be tightly controlled, to ensure the right proteins are made in the right amounts at the right time, and must be accurate, to avoid errors that could lead to the production of defective and potentially damaging proteins. In addition to the ribosome, protein synthesis also requires proteins termed translation factors, which mediate specific steps of the process. The first major stage of mRNA translation is termed 'initiation' and involves the recruitment of the ribosome to the mRNA and the identification of the correct start codon to commence translation. In eukaryotic cells, this process requires a set of eIFs (eukaryotic initiation factors). During the second main stage of translation, 'elongation', the ribosome traverses the coding region of the mRNA, assembling the new polypeptide: this process requires eEFs (eukaryotic elongation factors). Control of eEF2 is important in certain neurological processes. It is now clear that defects in eIFs or in their control can give rise to a number of diseases. This paper provides an overview of translation initiation and its control mechanisms, particularly those examined in neuronal cells. A major focus concerns an inherited neurological condition termed VHM (vanishing white matter) or CACH (childhood ataxia with central nervous system hypomyelination). VWM/CACH is caused by mutations in the translation initiation factor, eIF2B, a component of the basal translational machinery in all cells.
This record has no associated files available for download.
More information
Published date: 2009
Keywords:
autism spectrum disorder (asd), childhood ataxia with central nervous system hypomyelination (cach), disease, eukaryotic initiation factor 2B (eIF2B), protein synthesis, vanishing white matter (vwm)
Organisations:
Centre for Biological Sciences
Identifiers
Local EPrints ID: 350249
URI: http://eprints.soton.ac.uk/id/eprint/350249
ISSN: 0300-5127
PURE UUID: c5cd5726-3a40-4385-a0cc-92babc31c3a6
Catalogue record
Date deposited: 20 Mar 2013 12:30
Last modified: 14 Mar 2024 13:23
Export record
Altmetrics
Contributors
Author:
Graham D. Pavitt
Author:
Christopher G. Proud
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics